- ICH GCP
- US Clinical Trials Registry
- Researchers
- France
- Pancreatic Cancer
Medical specialists from France tagged as investigators in clinical trials studying Pancreatic Cancer
Total 205 results
-
Benjamin BesseSeen in:
- Val-de-Marne, Villejuif, Gustave Roussy
- Villejuif Cedex, Gustave Roussy
- Villejuif, IGR Gustave Roussy
Trials:- NCT04819100 (Principal Investigator)
- NCT03906331 (Principal Investigator)
- NCT04710628 (Principal Investigator)
- NCT03157128 (Principal Investigator)
Conditions:- Carcinoma, Non-Small-Cell Lung;
- Breast Cancer;
- Pancreatic Cancer;
- Non Small Cell Lung Cancer;
- Colon Cancer;
- Medullary Thyroid Cancer;
- Papillary Thyroid Cancer;
- Other Solid Tumors With Evidence of Activating RET Alteration;
- Metastatic Thymic Carcinoma;
- Thymoma Type B3;
- Non-Small Cell Lung Cancer;
- Any Solid Tumor
-
Bruno HEYD, PrSeen in:
- Besançon, Centre Hospitalier Régional Universitaire de Besançon
Trials:- NCT02818907 (Principal Investigator)
Conditions: -
Bruno LANDISeen in:
- Paris, HEGP
- Paris, Hôpital Européen Georges Pompidou
Trials:- NCT02355379 (Sub-Investigator)
- NCT03693677 (Sub-Investigator)
Conditions: -
Byeul-A KIM, MDSeen in:
- Lyon, Service de Gériatrie aigue, Hôpital Edouard Herriot, Hospices Civils de Lyon
- Lyon, Service de Médecine du vieillissement, Hôpital Edouard Herriot, HCL
Trials:- NCT03296150 (Principal Investigator)
- NCT06079229 (Principal Investigator)
Conditions: -
Carlos Alberto GOMEZ-ROCA, MDSeen in:
- Toulouse, IUCT Oncopole
Trials:- NCT03915678 (Principal Investigator)
-
Carole VITELLIUSSeen in:
- Angers, CHU Hotel Dieu
Trials:- NCT03693677 (Principal Investigator)
Conditions: -
Caroline EvenSeen in:
- Other, Villejuif Cedex, Institut Gustave Roussy
- Villejuif Cedex, GSK Investigational Site
- Villejuif, Gustave Roussy
Trials:- NCT03485209 (Principal Investigator)
- NCT04420884 (Principal Investigator)
- NCT03088059 (Principal Investigator)
- NCT06062420 (Principal Investigator)
-
Caroline PETORINSeen in:
- Clermont-Ferrand, Chu Estaing
Trials:- NCT03693677 (Principal Investigator)
Conditions: -
Caroline RobertSeen in:
- Other, Villejuif Cedex, Institut Gustave Roussy
- Villejuif, Gustave Roussy
Trials:- NCT05571839 (Principal Investigator)
- NCT05529316 (Principal Investigator)
- NCT03235245 (Principal Investigator)
-
Cécile JULIENSeen in:
- Marseille, Hôpital Européen
Trials:- NCT03693677 (Sub-Investigator)
Conditions: -
Cédric LECAILLE, MDSeen in:
- Bordeaux, Polyclinique Bordeaux Nord
- Bordeaux, Polyclinique Bordeaux Nord Aquitaine
Trials:- NCT04166604 (Principal Investigator)
- NCT02184663 (Principal Investigator)
- NCT03704480 (Principal Investigator)
- NCT04348045 (Principal Investigator)
-
Céline LEPERESeen in:
- Paris, CHU - Hôpital Européen George Pompidou
- Paris, HEGP
- Paris, Hôpital Européen Georges Pompidou
Trials:- NCT02355379 (Sub-Investigator)
- NCT03693677 (Sub-Investigator)
- NCT02885753 (Sub-Investigator)
-
Chirstophe LOCHERSeen in:
- Meaux, CH
Trials:- NCT03693677 (Principal Investigator)
Conditions: -
Chloé MARECHALSeen in:
- Vandœuvre-lès-Nancy, CHRU de Nancy
Trials:- NCT03693677 (Sub-Investigator)
Conditions: -
Christophe BorgSeen in:
- Besancon, Centre Hospitalier Régional et Universitaire de Besançon - Hôpital Jean-Minjoz
- Besançon cedex, GSK Investigational Site
- Besançon, CHU de Besançon
- Besançon, Service d'Oncologie Medicale - CHRU Besancon
- Other, Besancon Cedex, Centre Hospitalier Régional et Universitaire de Besançon - Hôpital Jean-Minjoz
- Other, Besancon, Hospitalier Jean Minjoz
Trials:- NCT05608044 (Principal Investigator)
- NCT03485209 (Principal Investigator)
- NCT04420884 (Principal Investigator)
- NCT05253651 (Principal Investigator)
- NCT05723562 (Principal Investigator)
- NCT03400072 (Principal Investigator)
-
Christophe Tournigand, MD PhDSeen in:
- Creteil, Hopital Henri Mondor
- Créteil, Hopital Henri Mondor
Trials:- NCT03400072 (Principal Investigator)
- NCT02184663 (Principal Investigator)
-
Cindy Neuzillet, MDSeen in:
- Créteil, Hopital Henri Mondor
- Saint-Cloud, Institut Curie
Trials:- NCT03400072 (Sub-Investigator)
Conditions: -
Claire CAPELLESeen in:
- Boulogne-sur-Mer, CH Duchenne
Trials:- NCT03693677 (Sub-Investigator)
Conditions: -
Claire GALLOISSeen in:
- Paris, Hôpital Européen Georges Pompidou
Trials:- NCT03693677 (Sub-Investigator)
Conditions: -
Claude El Kouri, MDSeen in:
- Other, Nantes Cedex 2, Hopital Prive Du Confluent
Trials:- NCT03485209 (Principal Investigator)
-
Clélia COUTZACSeen in:
- Paris, CHU - Hôpital Européen George Pompidou
- Paris, Hôpital Européen Georges Pompidou
Trials:- NCT03693677 (Sub-Investigator)
- NCT02885753 (Sub-Investigator)
Conditions: -
Côme Lepage, PrSeen in:
- Bourgogne, Dijon, Chu de Dijon
- Dijon, CHU
Trials:- NCT03693677 (Sub-Investigator)
- NCT02738359 (Sub-Investigator)
Conditions: -
David ANCELSeen in:
- Paris, Hôpital Tenon
Trials:- NCT03693677 (Sub-Investigator)
Conditions: -
David PASQUIER, MDSeen in:
- Lille Cedex, Centre Oscar Lambret
- Lille, Centre Oscar Lambret
Trials:- NCT04536805 (Principal Investigator)
- NCT04498767 (Principal Investigator)
- NCT03915678 (Principal Investigator)
Conditions:- Prostate Cancer;
- Melanoma;
- Sarcoma;
- Head and Neck Cancer;
- Gynecologic Cancer;
- Gastric Cancer;
- Pancreatic Cancer;
- Esophageal Cancer;
- Small Bowel Cancer;
- Bladder Cancer;
- Skin Cancer;
- Colon Cancer;
- Renal Cancer;
- Oligometastasis;
- Hepatobiliary Cancer;
- Upper Urinary Tract Carcinoma;
- Non Small Cell Lung Cancer;
- Triple Negative Breast Cancer;
- Solid Tumor, Adult;
- Virus-associated Tumors
-
David SEFRIOUISeen in:
- Rouen, CHU Charles Nicolle
Trials:- NCT03693677 (Sub-Investigator)
Conditions: -
David TAIEB, MDSeen in:
- Marseille, Assistance Publique Hopitaux De Marseille
Trials:- NCT02150408 (Principal Investigator)
Conditions: -
David TougeronSeen in:
- Other, Poitiers, Centre Hospitalier Universitaire de Poitiers
- Poitiers, CHU
- Poitiers, CHU Hôpital de la Miletrie
- Poitiers, CHU Poitiers
- Poitiers, CHU Poitiers - Pole Regional de Cancerologie de Poitiers (PRC)
- Poitiers, CHU de Poitiers
- Poitiers, Centre Hospitalier Regional Universitaire Poitiers
Trials:- NCT05254639 (Principal Investigator)
- NCT03800212 (Principal Investigator)
- NCT05608044 (Principal Investigator)
- NCT04874207 (Principal Investigator)
- NCT02885753 (Principal Investigator)
- NCT05253651 (Principal Investigator)
- NCT05945823 (Principal Investigator)
Conditions:- Digestive Oncology;
- Supportive Care;
- Ampullary Adenocarcinoma;
- Metastatic Colorectal Cancer;
- Colorectal Cancer Metastatic;
- Colorectal Neoplasms;
- Pancreatic Cancer;
- Esophageal Adenocarcinoma;
- Esophageal Squamous Cell Cancer;
- Locally Advanced Unresectable or Metastatic Solid Tumors Including Esophageal Cancer;
- Siewert Type 1 GEJ Cancer
Clinical Trials on Pancreatic Cancer
-
City of Hope Medical CenterRecruitingPancreatic Neoplasms | Pancreatic Cancer | Pancreatic Adenocarcinoma | Pancreatic Ductal Adenocarcinoma | Pancreatic Cancer Resectable | Pancreatic Carcinoma | Pancreatic Cancer Non-resectable | Pancreatic Cancer Stage III | Pancreatic Cancer Stage | Pancreatic Cancer Stage II | Pancreatic Cancer, Adult | Pancreatic... and other conditionsKorea, Republic of, United States, Japan
-
Sidney Kimmel Cancer Center at Thomas Jefferson...CelgeneWithdrawnPancreatic Ductal Adenocarcinoma | Stage III Pancreatic Cancer | Stage IV Pancreatic Cancer | Stage IIA Pancreatic Cancer | Stage IIB Pancreatic Cancer | Stage IA Pancreatic Cancer | Stage IB Pancreatic CancerUnited States
-
University of NebraskaNational Cancer Institute (NCI)CompletedPancreatic Adenocarcinoma | Stage III Pancreatic Cancer | Stage IIA Pancreatic Cancer | Stage IIB Pancreatic Cancer | Stage II Pancreatic Cancer | Stage I Pancreatic Cancer | Resectable Pancreatic Carcinoma | Stage IA Pancreatic Cancer | Stage IB Pancreatic CancerUnited States
-
Virginia Commonwealth UniversityNational Cancer Institute (NCI)CompletedPancreatic Adenocarcinoma | Recurrent Pancreatic Carcinoma | Stage III Pancreatic Cancer | Stage IIA Pancreatic Cancer | Stage IIB Pancreatic Cancer | Stage IA Pancreatic Cancer | Stage IB Pancreatic CancerUnited States
-
Case Comprehensive Cancer CenterNational Cancer Institute (NCI)TerminatedPancreatic Adenocarcinoma | Resectable Pancreatic Cancer | Stage III Pancreatic Cancer | Stage IIA Pancreatic Cancer | Stage IIB Pancreatic Cancer | Stage IA Pancreatic Cancer | Stage IB Pancreatic Cancer | Poorly Differentiated Malignant Neoplasm | Undifferentiated Pancreatic CarcinomaUnited States
-
Case Comprehensive Cancer CenterNational Cancer Institute (NCI)WithdrawnStage IIA Pancreatic Cancer | Stage IIB Pancreatic Cancer | Stage IA Pancreatic Cancer | Stage IB Pancreatic Cancer
-
National Cancer Institute (NCI)CompletedStage IIA Pancreatic Cancer | Stage IIB Pancreatic Cancer | Stage IA Pancreatic Cancer | Stage IB Pancreatic CancerUnited States
-
University of UtahNovartis PharmaceuticalsRecruitingMetastatic Pancreatic Carcinoma | Unresectable Pancreatic Carcinoma | Stage III Pancreatic Cancer | Stage IV Pancreatic Cancer | Stage IIA Pancreatic Cancer | Stage IIB Pancreatic Cancer | Stage II Pancreatic CancerUnited States
-
Shanghai Zhongshan HospitalFudan UniversityNot yet recruitingPancreatic Cancer Stage III | Pancreatic Cancer, Stage IB | Pancreatic Cancer, Stage IIA | Pancreatic Cancer, Stage IIBChina
-
University of Wisconsin, MadisonCompletedStage IIA Pancreatic Cancer | Stage IIB Pancreatic Cancer | Stage IA Pancreatic Cancer | Stage IB Pancreatic CancerUnited States